IS MAGNITUDE OF INITIAL RESPONSE PREDICTIVE FOR SURVIVAL IN MULTIPLE-MYELOMA

被引：7

作者：

DURIE, BGM

机构：

来源：

ANNALS OF ONCOLOGY | 1991年 / 2卷 / 03期

关键词：

D O I：

10.1093/oxfordjournals.annonc.a057895

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：166 / 166

页数：1

共 9 条

[1] IS AGGRESSIVE CHEMOTHERAPY MORE EFFECTIVE IN THE TREATMENT OF PLASMA-CELL MYELOMA
BERGSAGEL, DE
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02): : 159 - 161
[2] EARLY RESPONDER MYELOMA - KINETIC-STUDIES IDENTIFY A PATIENT SUBGROUP CHARACTERIZED BY VERY POOR PROGNOSIS
BOCCADORO, M
MARMONT, F
TRIBALTO, M
FOSSATI, G
REDOGLIA, V
BATTAGLIO, S
MASSAIA, M
GALLAMINI, A
COMOTTI, B
BARBUI, T
CAMPOBASSO, N
DAMMACCO, F
CANTONETTI, M
PETRUCCI, MT
MANDELLI, F
RESEGOTTI, L
PILERI, A
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (01) : 119 - 125
[3] DURIE BGM, 1989, EUR J HAEMATOL, V43, P111
[4] DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO
[5] 2-U
[6] LACK OF CORRELATION BETWEEN OBJECTIVE RESPONSE AND DEATH RATE IN MULTIPLE-MYELOMA PATIENTS TREATED WITH ORAL MELPHALAN AND PREDNISONE
MARMONT, F
LEVIS, A
FALDA, M
RESEGOTTI, L
[J]. ANNALS OF ONCOLOGY, 1991, 2 (03) : 191 - 195
[7] ARE THE CURRENT CRITERIA FOR RESPONSE USEFUL IN THE MANAGEMENT OF MULTIPLE-MYELOMA
PALMER, M
BELCH, A
BROX, L
POLLOCK, E
KOCH, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) : 1373 - 1377
[8] MULTIPLE-MYELOMA TREATED WITH HIGH-DOSE INTRAVENOUS MELPHALAN
SELBY, PJ
MCELWAIN, TJ
NANDI, AC
PERREN, TJ
POWLES, RL
TILLYER, CR
OSBORNE, RJ
SLEVIN, ML
MALPAS, JS
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (01) : 55 - 62
[9] THOUGHTS ON CANCER CHEMOTHERAPY AND COMBINATION MODALITY THERAPY (1974)
SKIPPER, HE
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 230 (07): : 1033 - 1035

← 1 →